Reports
Sale
Global Therapeutic Drug Monitoring Market Size, Share, Report: By Product Type: Consumables, Devices; By Type: Immunoassays, Proteomic Technologies; By Drug Class: Antiepileptic, Antiarrhythmic, Immunosuppressants, Antibiotic Drugs, Bronchodilator Drugs, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Therapeutic Drug Monitoring Market Outlook
The global therapeutic drug monitoring market size was valued at USD 2.2 billion in 2022, driven by the emphasis on evaluating a drugs’ efficacy in a patient and precision medicine across the globe. The market is expected to grow at a CAGR of 9.1% during the forecast period of 2024-2032, with the values likely to rise from USD 2.4 billion in 2024 to USD 4.8 billion by 2032.
Therapeutic Drug Monitoring: Introduction
Therapeutic drug monitoring is the periodic measurement of several drugs in the bloodstream. It is an evaluation to ensure that a patient is adhering to the prescribed dosage. It is also used to gauge the effectiveness of the medications.
Therapeutic drug monitoring is used to optimize the dosages for people who are taking certain medicines, which can be hard to dose due to potential side effects. Such medicines may range from antibiotics, heart drugs, anti-seizure drugs, and drugs to treat autoimmune diseases. It is also known as medicine levels blood test or therapeutic drug levels test.
Global Therapeutic Drug Monitoring Market Analysis
Therapeutic drug monitoring plays a critical role in clinical practice. Monitoring drug levels in individual patients allows for patient-specific dose optimisation. Therefore, there has been a notable upswing in the therapeutic drug monitoring market demand, particularly with precision medicine gaining prominence in today’s healthcare system.
Conventional therapeutic drug monitoring techniques are time-consuming and labour-intensive. They require large sample volumes, along with a substantial number of organic solvents. In some cases, samples must be sent to central laboratories for analysis as well, potentially causing a delay in getting the required results. In this regard, Raman spectroscopy has emerged as a promising technique that offers label-free and non-invasive characteristics that also facilitate smooth, rapid, and precise analysis.
Furthermore, UCL researchers have also developed a new drug-monitoring tool called ChromaDose that calculates the efficacy of cancer medicine in a patient’s bloodstream. It is aimed at reducing heart issues and other side effects experienced by kids receiving chemotherapy. This point-of-care tool can be made available in hospitals by 2025. In addition, there has been ongoing research on dual-colour bioluminescent sensor proteins for therapeutic drug monitoring of antitumor antibodies. As research and development continue to progress, therapeutic drug monitoring market value will increase in the forecast period.
Global Therapeutic Drug Monitoring Market Segmentation
Market Breakup by Product Type
- Consumables
- Devices
- Immunoassay Analyzers
- Chromatography and MS Detectors
- Clinical Chemistry Analyzers
- Others
Market Breakup by Type
- Immunoassays
- Proteomic Technologies
Market Breakup by Drug Class
- Antiepileptic
- Antiarrhythmic
- Immunosuppressants
- Antibiotic Drugs
- Bronchodilator Drugs
- Psychoactive Drugs
- Others
Market Breakup by End User
- Hospitals
- Commercial and Private Laboratories
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Therapeutic Drug Monitoring Market Overview
With the prominence of precision medicine, researchers have turned towards therapeutic drug monitoring for treating diseases where accurate measurement of drugs plays a vital role in the treatment. For instance, in diseases like inflammatory bowel disease and paediatric cystic fibrosis treatment, therapeutic drug monitoring is being used to enhance treatment outcomes. This indicates the certainty of therapeutic drug monitoring market growth in upcoming years.
Considering the growing population, developing infrastructure, and increased technical advancements in the Asia Pacific region, the market for therapeutic drug monitoring is expected to observe a steep growth. Increased awareness regarding diagnostics is another factor fuelling the growth, in contrast to the historical period, when the United States led the therapeutic drug monitoring market share. This can be attributed to the presence of major healthcare giants in the area, committed to work on new innovations, envisioned at improving patient treatment and overall experience.
Global Therapeutic Drug Monitoring Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
- Siemens Healthineers AG
- Danaher Corporation
- Bio-Rad Laboratories
- Biomérieux SA
- Theradiag
- Grifols S.A.
- Exagen Inc.
- Ark Diagnostics, Inc.
- R-Biopharm A
- Apdia Group
- Biotez Berlin Buch GmbH
- Eagle Biosciences, Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
|
Breakup by Type |
|
| Breakup by Drug Class |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Therapeutic Drug Monitoring Market Overview
3.1 Global Therapeutic Drug Monitoring Market Historical Value (2017-2023)
3.2 Global Therapeutic Drug Monitoring Market Forecast Value (2024-2032)
4 Global Therapeutic Drug Monitoring Market Landscape
4.1 Global Therapeutic Drug Monitoring Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Therapeutic Drug Monitoring Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by Drug Class
5 Global Therapeutic Drug Monitoring Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Therapeutic Drug Monitoring Market Segmentation
6.1 Global Therapeutic Drug Monitoring Market by Product Type
6.1.1 Market Overview
6.1.2 Consumables
6.1.3 Devices
6.1.3.1 Immunoassay Analyzers
6.1.3.2 Chromatography and Ms Detectors
6.1.3.3 Clinical Chemistry Analyzers
6.1.3.4 Others
6.2 Global Therapeutic Drug Monitoring Market by Type
6.2.1 Market Overview
6.2.2 Immunoassays
6.2.3 Proteomic Technologies
6.3 Global Therapeutic Drug Monitoring Market by Drug Class
6.3.1 Market Overview
6.3.2 Antiepileptic
6.3.3 Antiarrhythmic
6.3.4 Immunosuppressants
6.3.5 Antibiotic Drugs
6.3.6 Bronchodilator Drugs
6.3.7 Psychoactive Drugs
6.3.8 Others
6.4 Global Therapeutic Drug Monitoring Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Commercial and Private Laboratories
6.4.4 Others
6.5 Global Therapeutic Drug Monitoring Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Therapeutic Drug Monitoring Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Therapeutic Drug Monitoring Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Therapeutic Drug Monitoring Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Therapeutic Drug Monitoring Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Therapeutic Drug Monitoring Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding & Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 ABBOTT
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisition
16.1.5 Certifications
16.2 THERMO FISHER SCIENTIFIC
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisition
16.2.5 Certifications
16.3 F. HOFFMANN-LA ROCHE
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisition
16.3.5 Certifications
16.4 SIEMENS HEALTHINEERS AG
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisition
16.4.5 Certifications
16.5 DANAHER CORPORATION
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisition
16.5.5 Certifications
16.6 BIO-RAD LABORATORIES
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisition
16.6.5 Certifications
16.7 BIOMÉRIEUX SA
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisition
16.7.5 Certifications
16.8 THERADIAG
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisition
16.8.5 Certifications
16.9 GRIFOLS S.A.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisition
16.9.5 Certifications
16.10 EXAGEN INC.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisition
16.10.5 Certifications
16.11 ARK DIAGNOSTICS, INC.
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisition
16.11.5 Certifications
16.12 R-BIOPHARM A
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisition
16.12.5 Certifications
16.13 APDIA GROUP
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisition
16.13.5 Certifications
16.14 BIOTEZ BERLIN BUCH GMBH
16.14.1 Financial Analysis
16.14.2 Product Portfolio
16.14.3 Demographic Reach and Achievements
16.14.4 Mergers and Acquisition
16.14.5 Certifications
16.15 EAGLE BIOSCIENCES, INC.
16.15.1 Financial Analysis
16.15.2 Product Portfolio
16.15.3 Demographic Reach and Achievements
16.15.4 Mergers and Acquisition
16.15.5 Certifications
17 Global Therapeutic Drug Monitoring Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 2.2 billion in 2023, driven by the emphasis on analysing the effectiveness of a particular in a patient’s bloodstream.
The market is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032, likely to reach a market value of USD by 4.8 billion in 2032.
The evolution from time-consuming and labour-intensive methods to rapid and non-invasive drug monitoring devices has been a key factor for market growth. The prevalence of precision medicine is another critical aspect.
New methods and tools like Raman spectroscopy and ChromaDose are being used to offer accurate, rapid, and non-invasive analysis for patients. North America has led the market share in historic period, which currently seems to shift towards the Asia Pacific region.
Immunoassays and proteomic technologies are different types of therapeutic drug monitoring.
Product types can be divided into consumables and devices like immunoassay analysers, chromatography and MS detectors, and clinical chemistry analysers, among others.
Drug classes included are antiepileptic, antiarrhythmic, immunosuppressants, antibiotic drugs, bronchodilator drugs, and psychoactive drugs, among others.
Hospitals, commercial and private laboratories, among others are the major end users.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Abbott, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers AG, Bio-Rad Laboratories, Biomérieux Sa, Theradiag, Grifols S.A., Exagen Inc., Ark Diagnostics, Inc., R-Biopharm A, Apdia Group, Biotez Berlin Buch GmbH, Eagle Biosciences, Inc., and Danaher Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER